ask="2.07"
ask_size="4000"
average_daily_volume="221887"
bid="1.96"
bid_size="100"
book_value="3.15"
change="+0.17"
change_from_200_day_moving_average="-0.25"
change_from_50_day_moving_average="0.01"
change_from_52_week_high="-6.30"
change_From_52_week_low="0.30"
change_in_percent="+9.34%"
close="1.99"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.70"
ebitda="-56.49M"
eps_estimate_current_year="-5.24"
eps_estimate_next_quarter="-0.77"
eps_estimate_next_year="-2.96"
ex_dividend_date="N/A"
float_shares="14394000"
high="2.07"
high_52_weeks="8.29"
last_trade_date="3/14/2017"
last_trade_price="1.99"
last_trade_size="1246"
last_trade_time="4:00pm"
low="1.75"
low_52_weeks="1.69"
market_capitalization="40.29M"
moving_average_200_day="2.24"
moving_average_50_day="1.98"
name="Aptevo Therapeutics Inc."
notes="N/A"
one_year_target_price="5.00"
open="1.80"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-10.98%"
percent_change_from_50_day_moving_average="+0.62%"
percent_change_from_52_week_high="-76.00%"
percent_change_from_52_week_low="+17.75%"
previous_close="1.82"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.58"
price_per_sales="1.03"
revenue="35.95M"
shares_outstanding="20248000"
short_ratio="3.74"
stock_exchange="NMS"
symbol="APVO"
volume="520576"
weeks_range_52="1.69 - 8.29"
